Before PSM | After PSM | |||||
---|---|---|---|---|---|---|
T2D | No diabetes | P | T2D | No diabetes | P | |
N | 889 | 3816 | NA | 889 | 889 | NA |
Year 2202 − 2005, n(%) | 171(20.17) | 757(21.14) | 0.388 | 171(20.17) | 171(20.45) | 0.362 |
Year 2006–2009, n(%) | 181(21.34) | 762(21.28) | 181(21.34) | 185(22.13) | ||
Year 2010–2013, n(%) | 154(18.16) | 621(17.34) | 154(18.16) | 131(15.67) | ||
Year 2014–2017, n(%) | 156(18.4) | 739(20.64) | 156(18.4) | 180(21.53) | ||
Year 2018–2021, n(%) | 186(21.93) | 702(19.6) | 186(21.93) | 169(20.22) | ||
Women, n (%) | 131(14.74) | 886(23.22) | < 0.001 | 131(14.74) | 116(13.05) | 0.304 |
Age, mean (SD) | 58.91(7.02) | 54.99(8.93) | < 0.001 | 58.91(7.02) | 59.19(7.69) | 0.421 |
35–49 years, n (%) | 90(10.12) | 1016(26.62) | < 0.001 | 90(10.12) | 98(11.02) | 0.601 |
50–59 years, n (%) | 347(39.03) | 1487(38.97) | 347(39.03) | 328(36.9) | ||
≥ 60 years, n (%) | 452(50.84) | 1313(34.41) | 452(50.84) | 463(52.08) | ||
CCI, mean (SD) | 1.8(1) | 1.63(0.89) | < 0.001 | 1.80(1.00) | 1.75(0.99) | 0.390 |
Peripheral vascular disease, n (%) | 190(21.37) | 619(16.22) | < 0.001 | 190(21.37) | 174(19.57) | 0.347 |
Cerebrovascular disease, n (%) | 51(5.74) | 196(5.14) | 0.470 | 51(5.74) | 47(5.29) | 0.678 |
Dementia, n (%) | 0(0) | 2(0.05) | 0.495 | 0(0) | 1(0.11) | 0.317 |
Chronic respiratory disease, n (%) | 153(17.21) | 648(16.98) | 0.870 | 153(17.21) | 152(17.1) | 0.950 |
Rheumatoid disease, n (%) | 3(0.34) | 35(0.92) | 0.082 | 3(0.34) | 3(0.34) | 1.000 |
Peptic ulcer, n (%) | 5(0.56) | 37(0.97) | 0.245 | 5(0.56) | 3(0.34) | 0.479 |
Mild liver disease, n (%) | 35(3.94) | 206(5.4) | 0.075 | 35(3.94) | 34(3.82) | 0.902 |
Hemiplegia or paraplegia, n (%) | 8(0.9) | 52(1.36) | 0.268 | 8(0.9) | 7(0.79) | 0.795 |
Renal disease, n (%) | 164(18.45) | 390(10.22) | < 0.001 | 164(18.45) | 141(15.86) | 0.148 |
Cancer, n (%) | 3(0.34) | 20(0.52) | 0.472 | 3(0.34) | 6(0.67) | 0.316 |
Moderate/Severe liver disease, n (%) | 12(1.35) | 33(0.86) | 0.181 | 12(1.35) | 11(1.24) | 0.834 |
AIDS, n (%) | 0(0) | 2(0.05) | 0.495 | 0(0) | 1(0.11) | 0.317 |
Obesity, n(%) | 66(7.42) | 134(3.51) | < 0.001 | 66(7.42) | 50(5.62) | 0.124 |
Pulmonary hypertension, n(%) | 126(14.17) | 516(13.52) | 0.610 | 126(14.17) | 116(13.05) | 0.489 |
Valvular heart disease, n(%) | 131(14.74) | 731(19.16) | 0.002 | 131(14.74) | 117(13.16) | 0.338 |
Dilated cardiomyopathy, n(%) | 541(60.85) | 2427(63.6) | 0.127 | 541(60.85) | 542(60.97) | 0.961 |
Ischemic heart disease, n(%) | 506(56.92) | 1643(43.06) | < 0.001 | 506(56.92) | 531(59.73) | 0.229 |
Congenital heart disease, n(%) | 10(1.12) | 123(3.22) | 0.001 | 10(1.12) | 11(1.24) | 0.826 |
Complications of HT, n(%) | 268(30.15) | 1293(33.88) | 0.033 | 268(30.15) | 301(33.86) | 0.093 |
Pneumonia, n (%) | 27(3.04) | 256(6.71) | < 0.001 | 27(3.04) | 62(6.97) | < 0.001 |
Staphylococcus bacteremia, n (%) | 41(4.61) | 259(6.79) | 0.017 | 41(4.61) | 58(6.52) | 0.079 |
Streptococcus bacteremia, n (%) | 5(0.56) | 15(0.39) | 0.485 | 5(0.56) | 3(0.34) | 0.479 |
Gram-negative bacteremia, n (%) | 48(5.4) | 308(8.07) | 0.007 | 48(5.4) | 70(7.87) | 0.036 |
Pseudomonas aeruginosa, n (%) | 31(3.49) | 132(3.46) | 0.967 | 31(3.49) | 31(3.49) | 1.000 |
Cytomegalovirus infection, n (%) | 20(2.25) | 161(4.22) | 0.006 | 20(2.25) | 26(2.92) | 0.370 |
Hemodialysis, n (%) | 84(9.45) | 564(14.78) | < 0.001 | 84(9.45) | 122(13.72) | 0.005 |
ECMO, n (%) | 57(6.41) | 364(9.54) | 0.003 | 57(6.41) | 89(10.01) | 0.006 |
Tracheostomy, n (%) | 39(4.39) | 315(8.25) | < 0.001 | 39(4.39) | 62(6.97) | < 0.001 |
LOHS, median (IQR) | 23(24) | 28(36) | < 0.001 | 23(24) | 28(36) | < 0.001 |
IHM, n(%) | 109(12.26) | 693(18.16) | < 0.001 | 109(12.26) | 163(18.34) | 0.018 |
Urgent hospital admission n(%) | 542(60.97) | 1944(50.94) | < 0.001 | 542(60.97) | 456(51.29) | < 0.001 |